ACTR-1, a novel human acyltransferase and uses thereof
AssigneeMillennium Pharmaceuticals, Inc.
InventorsRosana Kapeller-Libermann, Thomas Joseph Logan
Life of this patent
Estimating the term…
Loading patent…
AssigneeMillennium Pharmaceuticals, Inc.
InventorsRosana Kapeller-Libermann, Thomas Joseph Logan
Estimating the term…
The invention provides isolated nucleic acid molecules, designated ACTR-1 nucleic acid molecules, which encode novel acyltransferase family members. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing ACTR-1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an ACTR-1 gene has been introduced or disrupted. The invention still further provides isolated ACTR-1 proteins, fusion proteins, antigenic peptides and anti-ACTR-1 antibodies. Diagnostic methods utilizing compositions of the invention are also provided.
An isolated polypeptide selected from the group consisting of:
Dependencies are inferred from the claim text.